DK1266887T3 - Indenoindolonderivater, fremgangsmåde til fremstilling af disse derivater og farmaceutiske sammensætninger indeholdende disse - Google Patents

Indenoindolonderivater, fremgangsmåde til fremstilling af disse derivater og farmaceutiske sammensætninger indeholdende disse

Info

Publication number
DK1266887T3
DK1266887T3 DK02291463T DK02291463T DK1266887T3 DK 1266887 T3 DK1266887 T3 DK 1266887T3 DK 02291463 T DK02291463 T DK 02291463T DK 02291463 T DK02291463 T DK 02291463T DK 1266887 T3 DK1266887 T3 DK 1266887T3
Authority
DK
Denmark
Prior art keywords
alkyl
aryl
optionally substituted
groups
derivatives
Prior art date
Application number
DK02291463T
Other languages
Danish (da)
English (en)
Inventor
Michel Wierzbicki
Marie-Francoise Boussard
Anne Rousseau
Ghanem Atassi
Stephane Leonce
Nicolas Guilbaud
John Hickman
Alain Pierre
Laurence Kraus-Berthier
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of DK1266887T3 publication Critical patent/DK1266887T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/94[b, c]- or [b, d]-condensed containing carbocyclic rings other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK02291463T 2001-06-13 2002-06-12 Indenoindolonderivater, fremgangsmåde til fremstilling af disse derivater og farmaceutiske sammensætninger indeholdende disse DK1266887T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0107718A FR2826009B1 (fr) 2001-06-13 2001-06-13 Nouveaux derives d'indenoindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
DK1266887T3 true DK1266887T3 (da) 2005-10-31

Family

ID=8864253

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02291463T DK1266887T3 (da) 2001-06-13 2002-06-12 Indenoindolonderivater, fremgangsmåde til fremstilling af disse derivater og farmaceutiske sammensætninger indeholdende disse

Country Status (26)

Country Link
US (1) US6627650B2 (ru)
EP (1) EP1266887B1 (ru)
JP (1) JP3837090B2 (ru)
KR (1) KR100466068B1 (ru)
CN (1) CN1156446C (ru)
AR (1) AR034471A1 (ru)
AT (1) ATE302183T1 (ru)
AU (1) AU781768B2 (ru)
BR (1) BR0202279A (ru)
CA (1) CA2389766C (ru)
CZ (1) CZ20022083A3 (ru)
DE (1) DE60205538T2 (ru)
DK (1) DK1266887T3 (ru)
EA (1) EA004571B1 (ru)
ES (1) ES2247282T3 (ru)
FR (1) FR2826009B1 (ru)
HK (1) HK1052172A1 (ru)
HU (1) HUP0201992A3 (ru)
MX (1) MXPA02005808A (ru)
NO (1) NO322709B1 (ru)
NZ (1) NZ519522A (ru)
PL (1) PL354472A1 (ru)
PT (1) PT1266887E (ru)
SI (1) SI1266887T1 (ru)
SK (1) SK286055B6 (ru)
ZA (1) ZA200204757B (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006047231B4 (de) * 2006-10-04 2009-02-12 Hemmerling, Hans-Jörg, Dr. Substituierte Indeno[1,2-b]indolderivate als neue Hemmstoffe der Protein Kinase CK2 und ihre Verwendung als Tumor Therapeutika, Cytostatika und Diagnostika
EP3147323B2 (de) 2015-09-28 2022-12-28 Henkel AG & Co. KGaA Thermisch expandierbare zusammensetzungen mit polysaccharid

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6256471A (ja) * 1985-09-05 1987-03-12 Teikoku Hormone Mfg Co Ltd 含窒素四環式化合物
SE8902273D0 (sv) * 1989-06-22 1989-06-22 Univ Cincinnati Indenoindole compounds i
SE8902274D0 (sv) * 1989-06-22 1989-06-22 Univ Cincinnati Indenoidole compounds ii
SE9302431D0 (sv) * 1993-07-16 1993-07-16 Ab Astra Use of indenoindole compounds
US6069153A (en) * 1998-05-12 2000-05-30 American Home Products Corporation Indenoindoles and benzocarbazoles as estrogenic agents
FR2821843B1 (fr) * 2001-03-12 2003-05-09 Servier Lab Nouveaux derives d'isoindoloindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
NO20022794D0 (no) 2002-06-12
HUP0201992A3 (en) 2004-04-28
AU781768B2 (en) 2005-06-09
EA004571B1 (ru) 2004-06-24
JP3837090B2 (ja) 2006-10-25
EA200200563A1 (ru) 2002-12-26
SK286055B6 (sk) 2008-02-05
EP1266887A2 (fr) 2002-12-18
KR20020094914A (ko) 2002-12-18
HK1052172A1 (en) 2003-09-05
KR100466068B1 (ko) 2005-01-13
ATE302183T1 (de) 2005-09-15
PL354472A1 (en) 2002-12-16
AR034471A1 (es) 2004-02-25
FR2826009B1 (fr) 2003-08-15
CA2389766A1 (fr) 2002-12-13
FR2826009A1 (fr) 2002-12-20
CZ20022083A3 (cs) 2003-04-16
DE60205538D1 (de) 2005-09-22
MXPA02005808A (es) 2004-12-13
AU4590302A (en) 2002-12-19
PT1266887E (pt) 2005-10-31
EP1266887B1 (fr) 2005-08-17
HUP0201992A2 (hu) 2003-04-28
EP1266887A3 (fr) 2003-07-02
US20030125369A1 (en) 2003-07-03
ZA200204757B (en) 2003-02-17
ES2247282T3 (es) 2006-03-01
NZ519522A (en) 2003-11-28
BR0202279A (pt) 2003-04-29
HU0201992D0 (ru) 2002-08-28
CN1156446C (zh) 2004-07-07
SK8342002A3 (en) 2003-01-09
SI1266887T1 (sl) 2005-12-31
DE60205538T2 (de) 2006-06-14
US6627650B2 (en) 2003-09-30
NO322709B1 (no) 2006-11-27
CN1390834A (zh) 2003-01-15
JP2003012644A (ja) 2003-01-15
CA2389766C (fr) 2007-09-25
NO20022794L (no) 2002-12-16

Similar Documents

Publication Publication Date Title
AR006720A1 (es) Un compuesto derivado de azahexano heterociclico, su uso para la preparacion de una composicion farmaceutica, procedimiento para prepararlo y una composicion farmaceutica que lo comprende
PE20230820A1 (es) Derivados de biarilo como inhibidores de la interaccion proteina-proteina de yap/taz-tead
DE69507505D1 (de) Anilin derivate
WO2007070606A3 (en) Isoxazolines for controlling invertebrate pests
DK1333833T3 (da) Ny trisubstitueret 8H-pyridol[2,3-d]pyrimidin-7-on-forbindelse til behandling af CSBP/RK/p38-kinnasemedierede sygdomme
ATE469892T1 (de) Substituierte 1h-dihydropyrazole, ihre herstellung und verwendung
AR045761A1 (es) Derivados de 2-piridona como inhibidores de elastasa de neutrofilos
PE20030703A1 (es) Inhibidores de la 17b-hidroxiesteroide deshidrogenasa tipo 3
CY1106753T1 (el) Καρβαμιδικαι ενωσεις δια χρησιν εις προληψιν ή νοσηλειαν νευροεκφυλιστικων διαταραχων
CY1110956T1 (el) Παραγωγα πυριδο-πυραζινης χρησιμα ως ζιζανιοκτονες ενωσεις
MXPA03010629A (es) Agentes para control de plagas de invertebrados de diamina que contienen un anillo heterociclico, no aromatico.
ATE517885T1 (de) Substituierte pyrazolyl-harnstoff-derivate zur behandlung von krebs
PE20061305A1 (es) Compuestos derivados de fenilacetamidas como inhibidores de proteincinasas
AR033306A1 (es) Compuestos
BR0212186A (pt) Composto, composição e método para controle de pragas invertebradas
ES2393824T3 (es) Derivados de piridin-2-il-amino-1,2,4-tiadiazol como activadores de glucoquinasa para el tratamiento de diabetes mellitus
ATE90107T1 (de) Peptide mit collagenase hemmender wirkung.
PE20020467A1 (es) Compuestos de 1,4-dihidropiridina como antagonistas de bradicinina
MXPA04004593A (es) Triazoles fenilo-sustituidos y su uso como inhibidores selectivos de cinasa de tipo activina-5.
SE0400043D0 (sv) New compounds
CY1107703T1 (el) Υποκατεστημενες δικετοπιπεραζινες και χρηση αυτων ως ανταγωνιστες οξυτοκινης
MXPA04002649A (es) Diamidas insecticidas.
PE20030705A1 (es) Inhibidores de la 17beta-hidroxiesteroide deshidrogenasa tipo 3 para el tratamiento de enfermedades androgeno-dependientes
BRPI0407841A (pt) inibidores heterocìclicos de quinase
DE602004025302D1 (de) Aryloxy- und Arylthioxyacetophenon-Verbindungen zur Behandlung von Krebs